Your browser doesn't support javascript.
loading
Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. IMPACT-II Investigators. Integrilin (eptifibatide) to Minimize Platelet Aggregation and Coronary Thrombosis-II.
Tardiff, B E; Califf, R M; Tcheng, J E; Lincoff, A M; Sigmon, K N; Harrington, R A; Mahaffey, K W; Ohman, E M; Teirstein, P S; Blankenship, J C; Kitt, M M; Topol, E J.
Affiliation
  • Tardiff BE; Duke Clinical Research Institute, Durham, North Carolina 27710, USA. tardi002@mc.duke.edu
J Am Coll Cardiol ; 33(1): 88-96, 1999 Jan.
Article in En | MEDLINE | ID: mdl-9935014
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Platelet Aggregation Inhibitors / Coronary Disease / Creatine Kinase / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Cardiol Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peptides / Platelet Aggregation Inhibitors / Coronary Disease / Creatine Kinase / Myocardial Infarction Type of study: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Am Coll Cardiol Year: 1999 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos